# Amentum Holdings, Inc.: financial statements, quarterly AMTM · NYSE · CIK 2011286 · [Industrials](/sectors/industrials.md) · fiscal year ends Oct 2 Pages: [Overview](/companies/amtm.md) · [Financials](/companies/amtm/financials.md) · [Filings](/companies/amtm/filings.md) · [Insiders](/companies/amtm/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amtm/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,983](/filings/0002011286-25-000060.md) | [2,051](/filings/0002011286-25-000141.md) | [2,142](/filings/0002011286-25-000163.md) | [2,212 d](/filings/0001628280-25-053993.md) | [3,416](/filings/0001628280-26-006676.md) | [3,491](/filings/0001628280-26-034156.md) | [3,561](/filings/0001628280-26-055727.md) | [3,925 d](/filings/0001628280-25-053993.md) | [3,237](/filings/0001628280-26-006676.md) | [3,478](/filings/0001628280-26-034156.md) | [3,490](/filings/0001628280-26-055727.md) | | Cost of revenue | $m | [1,789](/filings/0002011286-25-000060.md) | [1,851](/filings/0002011286-25-000141.md) | [1,936](/filings/0002011286-25-000163.md) | [2,014 d](/filings/0001628280-25-053993.md) | [3,055](/filings/0001628280-26-006676.md) | [3,124](/filings/0001628280-26-034156.md) | [3,193](/filings/0001628280-26-055727.md) | [3,508 d](/filings/0001628280-25-053993.md) | [2,911](/filings/0001628280-26-006676.md) | [3,133](/filings/0001628280-26-034156.md) | [3,130](/filings/0001628280-26-055727.md) | | Selling, general and administrative | $m | [67.0](/filings/0002011286-25-000060.md) | [72.0](/filings/0002011286-25-000141.md) | [77.0](/filings/0002011286-25-000163.md) | [137 d](/filings/0001628280-25-053993.md) | [130](/filings/0001628280-26-006676.md) | [145](/filings/0001628280-26-034156.md) | [165](/filings/0001628280-26-055727.md) | [176 d](/filings/0001628280-25-053993.md) | [115](/filings/0001628280-26-006676.md) | [124](/filings/0001628280-26-034156.md) | [122](/filings/0001628280-26-055727.md) | | Operating income | $m | [86.0](/filings/0002011286-25-000060.md) | [89.0](/filings/0002011286-25-000141.md) | [89.0](/filings/0002011286-25-000163.md) | [27.0 d](/filings/0001628280-25-053993.md) | [132](/filings/0001628280-26-006676.md) | [110](/filings/0001628280-26-034156.md) | [103](/filings/0001628280-26-055727.md) | [135 d](/filings/0001628280-25-053993.md) | [138](/filings/0001628280-26-006676.md) | [151](/filings/0001628280-26-034156.md) | [172](/filings/0001628280-26-055727.md) | | Income tax | $m | [14.0](/filings/0002011286-25-000060.md) | [20.0](/filings/0002011286-25-000141.md) | [2.0](/filings/0002011286-25-000163.md) | [(76.0) d](/filings/0001628280-25-053993.md) | [24.0](/filings/0001628280-26-006676.md) | [22.0](/filings/0001628280-26-034156.md) | [13.0](/filings/0001628280-26-055727.md) | [(3.0) d](/filings/0001628280-25-053993.md) | [20.0](/filings/0001628280-26-006676.md) | [24.0](/filings/0001628280-26-034156.md) | [28.0](/filings/0001628280-26-055727.md) | | Net income | $m | [(41.0)](/filings/0002011286-25-000060.md) | [(41.0)](/filings/0002011286-25-000141.md) | [(26.0)](/filings/0002011286-25-000163.md) | [26.0 d](/filings/0001628280-25-053993.md) | [12.0](/filings/0001628280-26-006676.md) | [4.0](/filings/0001628280-26-034156.md) | [10.0](/filings/0001628280-26-055727.md) | [40.0 d](/filings/0001628280-25-053993.md) | [44.0](/filings/0001628280-26-006676.md) | [54.0](/filings/0001628280-26-034156.md) | [66.0](/filings/0001628280-26-055727.md) | | Diluted EPS | $ per share | [(0.46)](/filings/0002011286-25-000060.md) | [(0.46)](/filings/0002011286-25-000141.md) | [(0.29)](/filings/0002011286-25-000163.md) | not reported | [0.05](/filings/0001628280-26-006676.md) | [0.02](/filings/0001628280-26-034156.md) | [0.04](/filings/0001628280-26-055727.md) | not reported | [0.18](/filings/0001628280-26-006676.md) | [0.22](/filings/0001628280-26-034156.md) | [0.27](/filings/0001628280-26-055727.md) | | Basic EPS | $ per share | [(0.46)](/filings/0002011286-25-000060.md) | [(0.46)](/filings/0002011286-25-000141.md) | [(0.29)](/filings/0002011286-25-000163.md) | not reported | [0.05](/filings/0001628280-26-006676.md) | [0.02](/filings/0001628280-26-034156.md) | [0.04](/filings/0001628280-26-055727.md) | not reported | [0.18](/filings/0001628280-26-006676.md) | [0.22](/filings/0001628280-26-034156.md) | [0.27](/filings/0001628280-26-055727.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | period not labelled (2023-09-29) | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [0.3](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [0.5](/filings/0001628280-25-053993.md) | [0.5](/filings/0002011286-25-000060.md) | [0.5](/filings/0002011286-25-000141.md) | [0.7](/filings/0002011286-25-000163.md) | [0.4](/filings/0001628280-26-055727.md) | [0.2](/filings/0001628280-26-006676.md) | [0.4](/filings/0001628280-26-034156.md) | [0.5](/filings/0001628280-26-055727.md) | | Current assets | $bn | [1.9](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [3.1](/filings/0001628280-25-053993.md) | [3.1](/filings/0002011286-25-000060.md) | [3.3](/filings/0002011286-25-000141.md) | [3.4](/filings/0002011286-25-000163.md) | [3.1](/filings/0001628280-26-055727.md) | [3.0](/filings/0001628280-26-006676.md) | [3.1](/filings/0001628280-26-034156.md) | [3.2](/filings/0001628280-26-055727.md) | | Total assets | $bn | [6.4](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [12.0](/filings/0001628280-25-053993.md) | [11.9](/filings/0002011286-25-000060.md) | [12.0](/filings/0002011286-25-000141.md) | [11.8](/filings/0002011286-25-000163.md) | [11.5](/filings/0001628280-26-055727.md) | [11.2](/filings/0001628280-26-006676.md) | [11.2](/filings/0001628280-26-034156.md) | [11.2](/filings/0001628280-26-055727.md) | | Current liabilities | $bn | [1.4](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [2.0](/filings/0001628280-25-053993.md) | [2.0](/filings/0002011286-25-000060.md) | [2.1](/filings/0002011286-25-000141.md) | [2.2](/filings/0002011286-25-000163.md) | [2.4](/filings/0001628280-26-055727.md) | [2.1](/filings/0001628280-26-006676.md) | [2.1](/filings/0001628280-26-034156.md) | [2.1](/filings/0001628280-26-055727.md) | | Total liabilities | $bn | [6.0](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [7.4](/filings/0001628280-25-053993.md) | [7.4](/filings/0002011286-25-000060.md) | [7.4](/filings/0002011286-25-000141.md) | [7.2](/filings/0002011286-25-000163.md) | [6.8](/filings/0001628280-26-055727.md) | [6.5](/filings/0001628280-26-006676.md) | [6.5](/filings/0001628280-26-034156.md) | [6.4](/filings/0001628280-26-055727.md) | | Long-term debt | $bn | [4.1](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [4.6](/filings/0001628280-25-053993.md) | [4.6](/filings/0002011286-25-000060.md) | [4.6](/filings/0002011286-25-000141.md) | [4.4](/filings/0002011286-25-000163.md) | [3.9](/filings/0001628280-26-055727.md) | [3.9](/filings/0001628280-26-006676.md) | [3.9](/filings/0001628280-26-034156.md) | [3.8](/filings/0001628280-26-055727.md) | | Current portion of debt | $bn | [0.0](/filings/0002011286-24-000072.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-25-053993.md) | [0.0](/filings/0002011286-25-000060.md) | [0.0](/filings/0002011286-25-000141.md) | [0.0](/filings/0002011286-25-000163.md) | [0.0](/filings/0001628280-26-055727.md) | [0.0](/filings/0001628280-26-006676.md) | [0.0](/filings/0001628280-26-034156.md) | [0.1](/filings/0001628280-26-055727.md) | | Shareholders' equity | $bn | [0.4](/filings/0002011286-24-000072.md) | [0.4](/filings/0002011286-25-000141.md) | [0.3](/filings/0002011286-25-000163.md) | [0.3](/filings/0002011286-25-000163.md) | [4.5](/filings/0001628280-25-053993.md) | [4.5](/filings/0002011286-25-000060.md) | [4.4](/filings/0002011286-25-000141.md) | [4.5](/filings/0002011286-25-000163.md) | [4.5](/filings/0001628280-26-055727.md) | [4.6](/filings/0001628280-26-006676.md) | [4.6](/filings/0001628280-26-034156.md) | [4.7](/filings/0001628280-26-055727.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(83.0)](/filings/0002011286-25-000060.md) | [5.0 d](/filings/0002011286-25-000141.md) | [238 d](/filings/0002011286-25-000163.md) | [(113) d](/filings/0001628280-25-053993.md) | [110](/filings/0001628280-26-006676.md) | [57.0 d](/filings/0001628280-26-034156.md) | [106 d](/filings/0001628280-26-055727.md) | [270 d](/filings/0001628280-25-053993.md) | [(136)](/filings/0001628280-26-006676.md) | [225 d](/filings/0001628280-26-034156.md) | [146 d](/filings/0001628280-26-055727.md) | | Capital expenditure | $m | [2.0](/filings/0002011286-25-000060.md) | [3.0 d](/filings/0002011286-25-000141.md) | [2.0 d](/filings/0002011286-25-000163.md) | [4.0 d](/filings/0001628280-25-053993.md) | [8.0](/filings/0001628280-26-006676.md) | [4.0 d](/filings/0001628280-26-034156.md) | [6.0 d](/filings/0001628280-26-055727.md) | [9.0 d](/filings/0001628280-25-053993.md) | [6.0](/filings/0001628280-26-006676.md) | [5.0 d](/filings/0001628280-26-034156.md) | [11.0 d](/filings/0001628280-26-055727.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | period not labelled (2023-12-29) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [90.0](/filings/0002011286-25-000060.md) | [90.0](/filings/0002011286-25-000141.md) | [90.0](/filings/0002011286-25-000163.md) | [243](/filings/0001628280-26-006676.md) | [243](/filings/0001628280-26-034156.md) | [243](/filings/0001628280-26-055727.md) | [244](/filings/0001628280-26-006676.md) | [245](/filings/0001628280-26-034156.md) | [245](/filings/0001628280-26-055727.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 244,506,413 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001628280-26-055727.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.